Sartorius Stedim Biotech launches new Sartobind Cassettes for commercial applications

Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, has expanded its range of single-use membrane chromatography solutions with Sartobind® Cassettes. This convenient, pod-like modular system has been developed for commercial applications in both capture and polishing.

The newly developed Sartobind® cassette system is a unique single-use solution enabling large-scale bind and elute membrane chromatography.

New Sartobind® cassettes offer the same flow path, bed heights (4 and 8 mm) and void volume ratios as Sartobind® capsules, and are compatible with Q, S, STIC PA and phenyl ligands. The new design goes beyond the previous 5 L size limitation for capsule formats, expanding the boundaries of membrane chromatography. Multiple cassettes, each with 0.8 L or 1.6 L membrane volume, can be set up in three different stainless steel holders resulting in maximum membrane volumes of 20, 50 or 100 L, respectively. Data demonstrates direct scalability from the 3 mL Sartobind® nano capsule to 20.8 L (13 cassettes) in the Pilot Filter Holder. Pressure-flow performance and the shape of breakthrough curves are identical to the smaller capsule sizes, independent of the number of cassettes used. Set up can be accomplished within minutes, even at manufacturing scale, whether for capture applications or for flow-through removal of process contaminants.

The capture of large proteins such as viruses and virus-like particles (VLPs), protein conjugates and blood factors plays a key role in modern bioprocessing. The unique Sartobind® cassette system now enables large-scale bind-and-elute membrane chromatography for such targets. “For the first time, the high binding capacity of membrane adsorbers can be used at almost any scale in commercial vaccine manufacture. Now, a 200 L Q anion exchange column for adenovirus capture can be easily replaced by a 20 L Q adsorber cassette system”, says Dr. Stefan Fischer-Frühholz, membrane chromatography expert at Sartorius Stedim Biotech.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Sartorius. (2019, June 20). Sartorius Stedim Biotech launches new Sartobind Cassettes for commercial applications. News-Medical. Retrieved on November 22, 2024 from https://www.news-medical.net/news/20170911/Sartorius-Stedim-Biotech-launches-new-Sartobind-Cassettes-for-commercial-applications.aspx.

  • MLA

    Sartorius. "Sartorius Stedim Biotech launches new Sartobind Cassettes for commercial applications". News-Medical. 22 November 2024. <https://www.news-medical.net/news/20170911/Sartorius-Stedim-Biotech-launches-new-Sartobind-Cassettes-for-commercial-applications.aspx>.

  • Chicago

    Sartorius. "Sartorius Stedim Biotech launches new Sartobind Cassettes for commercial applications". News-Medical. https://www.news-medical.net/news/20170911/Sartorius-Stedim-Biotech-launches-new-Sartobind-Cassettes-for-commercial-applications.aspx. (accessed November 22, 2024).

  • Harvard

    Sartorius. 2019. Sartorius Stedim Biotech launches new Sartobind Cassettes for commercial applications. News-Medical, viewed 22 November 2024, https://www.news-medical.net/news/20170911/Sartorius-Stedim-Biotech-launches-new-Sartobind-Cassettes-for-commercial-applications.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Sartorius BIA Separations and Exopharm Sign Joint Research Agreement to Develop Integrated Technology